Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veal

Showing results (511-520 of 523) with videos related to

Pageof 53
Sort By:
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
Chemistry & Biology|July 28, 2010
Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90Patrick Fadden, Kenneth H Huang, James M Veal, et al.
Ear and Hearing|June 29, 2026
Avoiding Cisplatin-Related Hearing Loss, Including Implementing Sodium Thiosulfate as Otoprotectant Into Daily Pediatric Clinical Practice: Proceedings Based on Evidence and Expert Opinion From the Ototoxicity Taskforce of the SIOP Supportive Care NetworkNienke Streefkerk, James I Geller, Kristin Knight, et al.
Nature Communications|July 25, 2023
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trialJames Spicer, Bristi Basu, Ana Montes, et al.
JAMA Oncology|May 23, 2024
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled TrialNabil F Saba, Stuart J Wong, Tahseen Nasti, et al.
Journal of Medicinal Chemistry|June 26, 2009
Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agentsKenneth H Huang, James M Veal, R Patrick Fadden, et al.
Gigascience|September 20, 2024
An interconnected data infrastructure to support large-scale rare disease researchLennart F Johansson, Steve Laurie, Dylan Spalding, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2016
Insidious Risk of Severe Mycobacterium chimaera Infection in Cardiac Surgery PatientsMeera Chand, Theresa Lamagni, Katharina Kranzer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2023
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancerHarkeran K Jandu, Colin D Veal, Laura Fachal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron VariantRajesh M Valanparambil, Jennifer Carlisle, Susanne L Linderman, et al.
Pageof 53

Showing results (511-520 of 523) with videos related to

Sort By:
Pageof 53
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
Chemistry & Biology|July 28, 2010
Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90Patrick Fadden, Kenneth H Huang, James M Veal, et al.
Ear and Hearing|June 29, 2026
Avoiding Cisplatin-Related Hearing Loss, Including Implementing Sodium Thiosulfate as Otoprotectant Into Daily Pediatric Clinical Practice: Proceedings Based on Evidence and Expert Opinion From the Ototoxicity Taskforce of the SIOP Supportive Care NetworkNienke Streefkerk, James I Geller, Kristin Knight, et al.
Nature Communications|July 25, 2023
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trialJames Spicer, Bristi Basu, Ana Montes, et al.
JAMA Oncology|May 23, 2024
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled TrialNabil F Saba, Stuart J Wong, Tahseen Nasti, et al.
Journal of Medicinal Chemistry|June 26, 2009
Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agentsKenneth H Huang, James M Veal, R Patrick Fadden, et al.
Gigascience|September 20, 2024
An interconnected data infrastructure to support large-scale rare disease researchLennart F Johansson, Steve Laurie, Dylan Spalding, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2016
Insidious Risk of Severe Mycobacterium chimaera Infection in Cardiac Surgery PatientsMeera Chand, Theresa Lamagni, Katharina Kranzer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2023
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancerHarkeran K Jandu, Colin D Veal, Laura Fachal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron VariantRajesh M Valanparambil, Jennifer Carlisle, Susanne L Linderman, et al.
Pageof 53